GlassScriptPhysician profile
Louis Saffran
NPI 1881795839
$83,803.66
in general payments reported to CMS, 2019-2025
57 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,036 · 2020: $10K · 2021: $13K · 2022: $14K · 2023: $19K · 2024: $14K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $10K · Travel and Lodging: $878 · Education: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,300.00 |
| Food and Beverage | $10,472.73 |
| Travel and Lodging | $877.69 |
| Education | $592.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $45,286.33 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $21,654.91 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,483.00 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Harmony Biosciences LLC | $1,535.01 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $1,470.38 | 2023-2025 | Inspire |
| Philips North America LLC | $1,065.93 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy, Patient Interface Software |
| Jazz Pharmaceuticals INC. | $913.82 | 2019-2025 | Xywav |
| Regeneron Healthcare Solutions, INC. | $797.75 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $672.93 | 2019-2024 | Yupelri |
| Fisher & Paykel Healthcare INC | $571.62 | 2019-2025 | Fisher & Paykel Healthcare |
| Genzyme Corporation | $517.98 | 2021-2025 | |
| Electromed, INC. | $496.45 | 2019-2025 | Smartvest |
| Grifols USA, LLC | $493.15 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $467.45 | 2020-2025 | Opsumit, Uptravi |
| Advanced Respiratory, INC | $377.55 | 2019-2021 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $360.85 | 2020-2023 | Hyqvia |
| Baxter Healthcare | $325.74 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Hospital Products INC. | $322.82 | 2022-2024 | Acthar, Terlivaz |
| Inari Medical, INC. | $300.05 | 2022 | |
| Amgen INC. | $276.99 | 2021-2025 | Tezspire |
| Janssen Pharmaceuticals, INC | $271.21 | 2020-2024 | Xarelto |
| Pfizer INC. | $265.59 | 2019-2025 | |
| Chiesi USA, INC. | $244.53 | 2019-2021 | |
| Verona Pharma, INC. | $243.40 | 2025 | Ohtuvayre |
| Watermark Medical, INC. | $209.98 | 2021 | |
| Merck Sharp & Dohme LLC | $197.72 | 2021-2025 | Capvaxive, Zerbaxa |
| Shionogi INC | $171.48 | 2021-2025 | Fetroja |
| Zoll Respicardia, INC. | $138.48 | 2024-2025 | Remede System |
| Covidien LP | $134.25 | 2019 | |
| Inogen, INC. | $114.00 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $113.35 | 2020-2022 | |
| Abbvie INC. | $97.84 | 2022-2025 | Teflaro |
| Sanofi-Aventis U.S. LLC | $92.99 | 2025 | |
| Insmed, INC. | $89.18 | 2025 | Arikayce, Brinsupri |
| Ani Pharmaceuticals, INC. | $82.80 | 2023-2025 | Purified Cortrophin Gel |
| Itamar Medical INC | $82.72 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $79.60 | 2022-2023 | Quviviq |
| Viatris Specialty LLC | $76.29 | 2025 | Yupelri |
| Genentech USA, INC. | $72.66 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $70.59 | 2019-2020 | |
| Olympus America INC. | $60.70 | 2019 | |
| Sunovion Pharmaceuticals INC. | $54.73 | 2019 | |
| United Therapeutics Corporation | $53.73 | 2024 | Tyvaso |
| Gilead Sciences, INC. | $46.34 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $42.63 | 2020-2021 | |
| Circassia INC. | $34.44 | 2019 | |
| Coaptech, INC. | $31.73 | 2022 | |
| Phadia US INC. | $31.55 | 2022-2024 | Immunocap |
| Vapotherm INC | $29.36 | 2022 | |
| Boston Scientific Corporation | $29.33 | 2020 | |
| Resmed Corp | $26.54 | 2023 | |
| Eisai INC. | $24.97 | 2025 | |
| Lilly USA, LLC | $23.89 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $23.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.33 | 2019 | |
| Allergan, INC. | $18.21 | 2019 | |
| 3b Medical, INC. | $14.80 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Saffran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.